The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Colorectal cancer
Open accessAbstract
Colorectal cancer had a low incidence several decades ago. However, it has become a predominant cancer and now accounts for approximately 10% of cancer-related mortality in western countries. The ‘rise’ of colorectal cancer in developed countries can be attributed to the increasingly ageing population, unfavourable modern dietary habits and an increase in risk factors, such as smoking, low physical exercise and obesity. New treatments for primary and metastatic colorectal cancer have emerged, providing additional options for patients; these treatments include laparoscopic surgery for primary disease, more-aggressive resection of metastatic disease (such as liver and pulmonary metastases), radiotherapy for rectal cancer, and neoadjuvant and palliative chemotherapies. However, these new treatment options have had limited impact on cure rates and long-term survival. For these reasons, and the recognition that colorectal cancer is long preceded by a polypoid precursor, screening programmes have gained momentum. This Primer provides an overview of the current state of the art of knowledge on the epidemiology and mechanisms of colorectal cancer, as well as on diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Research works printed but not linked: 17
- De Jonge, V. et al. Quality evaluation of colonoscopy reporting and colonoscopy performance in daily clinical practice. Gastrointest. Endosc. 75, 98–106 (2012). · doi:10.1016/j.gie.2011.06.032
- Plumb, A. A. et al. CT colonography in the English Bowel Cancer Screening Programme: national survey of current practice. Clin. Radiol. 68, 479–487 (2013). · doi:10.1016/j.crad.2012.10.018
- Pooler, B. D., Kim, D. H., Lam, V. P., Burnside, E. S. & Pickhardt, P. J. CT Colonography Reporting and Data System (C-RADS): benchmark values from a clinical screening program. Am. J. Roentgenol. 202, 1232–1237 (2014). · doi:10.2214/ajr.13.11272
- Van Putten, P. G. et al. Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy 44, 1127–1132 (2012). · doi:10.1055/s-0032-1310154
- Van Dam, L., Kuipers, E. J., Steyerberg, E. W., van Leerdam, M. E. & de Beaufort, I. D. The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol. 14, e38–e46 (2013). · doi:10.1016/s1470-2045(12)70455-2
- Wilschut, J. A. et al. Fecal occult blood testing when colonoscopy capacity is limited. J. Natl Cancer Inst. 103, 1741–1751 (2011). · doi:10.1093/jnci/djr385
- van Hees, F. et al. Should colorectal cancer screening be considered in elderly persons without previous screening? Ann. Intern. Med. 160, 750–759 (2014). · doi:10.7326/m13-2263
- Jeffery, G. M., Hickey, B. E. & Hider, P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst. Rev. 1, CD002200 (2002).
- Quirke, P., West, N. P. & Nagtegaal, I. D. EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review. Virchows Arch. 464, 129–134 (2014). · doi:10.1007/s00428-013-1534-x
- Tudyka, V. et al. EURECCA consensus conference highlights about colon and rectal cancer multidisciplinary management: the radiology experts review. Eur. J. Surg. Oncol. 40, 469–475 (2014). · doi:10.1016/j.ejso.2013.10.029
- Van den Broek, C. B. M. et al. The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival. Eur. J. Surg. Oncol. 37, 904–912 (2011). · doi:10.1016/j.ejso.2011.06.013
- Dekker, J. W. T. et al. Cause of death the first year after curative colorectal cancer surgery; a prolonged impact of the surgery in elderly colorectal cancer patients. Eur. J. Surg. Oncol. 40, 1481–1487 (2014). · doi:10.1016/j.ejso.2014.05.010
- Doornebosch, P. G. et al. Transanal endoscopic microsurgery for T1 rectal cancer: size matters! Surg. Endosc. 26, 551–557 (2011). · doi:10.1007/s00464-011-1918-4
- Martin-Perez, B., Andrade-Ribeiro, G. D., Hunter, L. & Atallah, S. A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech. Coloproctol. 18, 775–788 (2014). · doi:10.1007/s10151-014-1148-6
- Ramji, K. M. et al. Comparison of clinical and economic outcomes between robotic, laparoscopic, and open rectal cancer surgery: early experience at a tertiary care center. Surg. Endosc. http://dx.doi.org/10.1007/s00464-015-4390-8 (2015). · doi:10.1007/s00464-015-4390-8
- Diouf, M. et al. Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study. Health Qual. Life Outcomes 12, 69 (2014). · doi:10.1186/1477-7525-12-69
- Gao, W., Gulliford, M., Bennett, M. I., Murtagh, F. E. M. & Higginson, I. J. Managing cancer pain at the end of life with multiple strong opioids: a population-based retrospective cohort study in primary care. PLoS ONE 9, e79266 (2014). · doi:10.1371/journal.pone.0079266
Cited by
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Genetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
Tian, Y., Ma, L., Gong, M., Su, G., Zhu, S., Zhang, W., Wang, S., Li, Z., Chen, C., Li, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07782 · Cited by 491
FXR Regulates Intestinal Cancer Stem Cell Proliferation
Fu, T., Coulter, S., Yoshihara, E., Oh, T. G., Fang, S., Cayabyab, F., Zhu, Q., Zhang, T., Leblanc, M., Liu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.036 · Cited by 456
Shang, A., Gu, C., Wang, W., Wang, X., Sun, J., Zeng, B., Chen, C., Chang, W., Ping, Y., Ji, P., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01235-0 · Cited by 436
Stefani, C., Miricescu, D., Stanescu-Spinu, I.-I., Nica, R. I., Greabu, M., Totan, A. R., & Jinga, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910260 · Cited by 402
Determinants and clinical implications of chromosomal instability in cancer
Sansregret, L., Vanhaesebroeck, B., & Swanton, C. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.198 · Cited by 396
Colorectal liver metastasis: molecular mechanism and interventional therapy
Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00922-2 · Cited by 298
Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers
Pang, Y., Zhao, L., Luo, Z., Hao, B., Wu, H., Lin, Q., Sun, L., & Chen, H. (2021) · Radiology · doi:10.1148/radiol.2020203275 · Cited by 298
Integrated Omics of Metastatic Colorectal Cancer
Li, C., Sun, Y.-D., Yu, G.-Y., Cui, J.-R., Lou, Z., Zhang, H., Huang, Y., Bai, C.-G., Deng, L.-L., Liu, P., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.002 · Cited by 297
Plant-derived bioactive compounds in colon cancer treatment: An updated review
Esmeeta, A., Adhikary, S., Dharshnaa, V., Swarnamughi, P., Ummul Maqsummiya, Z., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113384 · Cited by 293
Spaander, M. C. W., Zauber, A. G., Syngal, S., Blaser, M. J., Sung, J. J., You, Y. N., & Kuipers, E. J. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00432-7 · Cited by 288
Self-citationHeat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy
Yun, C. W., Kim, H. J., Lim, J. H., & Lee, S. H. (2019) · Cells · doi:10.3390/cells9010060 · Cited by 284
Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location
Mima, K., Cao, Y., Chan, A. T., Qian, Z. R., Nowak, J. A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.53 · Cited by 284
Surveillance after curative treatment for colorectal cancer
van der Stok, E. P., Spaander, M. C. W., Grünhagen, D. J., Verhoef, C., & Kuipers, E. J. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.199 · Cited by 272
Self-citationTumor-derived exosomes in the regulation of macrophage polarization
Baig, M. S., Roy, A., Rajpoot, S., Liu, D., Savai, R., Banerjee, S., Kawada, M., Faisal, S. M., Saluja, R., Saqib, U., et al. (2020) · Inflammation Research · doi:10.1007/s00011-020-01318-0 · Cited by 267
Hepatic Metastasis from Colorectal Cancer
Valderrama-Treviño, A. I., Barrera-Mera, B., Ceballos-Villalva, J. C., & Montalvo-Javé, E. E. (2017) · Euroasian Journal of Hepato-Gastroenterology · doi:10.5005/jp-journals-10018-1241 · Cited by 257
Screening for Colorectal Cancer
Gupta, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.02.001 · Cited by 212
Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16318 · Cited by 163
Guo, Y., Ayers, J. L., Carter, K. T., Wang, T., Maden, S. K., Edmond, D., Newcomb P, P., Li, C., Ulrich, C., Yu, M., et al. (2019) · Aging Cell · doi:10.1111/acel.13013 · Cited by 139
Self-citationPEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy
Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132
Doleschel, D., Hoff, S., Koletnik, S., Rix, A., Zopf, D., Kiessling, F., & Lederle, W. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02043-0 · Cited by 114
Feng, J., Hu, Z., Xia, X., Liu, X., Lian, Z., Wang, H., Wang, L., Wang, C., Zhang, X., & Pang, X. (2023) · Oncogene · doi:10.1038/s41388-023-02676-9 · Cited by 95
“Clinical treatments for CRC include laparoscopic surgery, radiotherapy, chemotherapy, and targeted therapy; however, owing to the extensive degree of heterogeneity of CRC, these treatment options still have a limited impact on the long-term survival of CRC patients [3, 4].”
BackgroundApoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway
Liu, Z., Li, Y., Zhu, Y., Li, N., Li, W., Shang, C., Song, G., Li, S., Cong, J., Li, T., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.64350 · Cited by 93
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“For advanced CRC cases, symptoms can include rectal bleeding, blood in stool, change in bowel habits, abdominal pain, abdominal mass, bowel obstruction, constipation, diarrhea, iron-deficiency anemia, weight loss, and fatigue [7,8].”
InfluentialGut-microbiota derived bioactive metabolites and their functions in host physiology
Debnath, N., Kumar, R., Kumar, A., Mehta, P. K., & Yadav, A. K. (2021) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2021.1989847 · Cited by 77
Liu, B., & Wang, H. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11321 · Cited by 56
Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance
Manzoor, S., Muhammad, J. S., Maghazachi, A. A., & Hamid, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924290 · Cited by 45
Pan, S., Guo, Y., Hong, F., Xu, P., & Zhai, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166281 · Cited by 37
Artificial intelligence in colonoscopy: A review on the current status
Larsen, S. L. V., & Mori, Y. (2022) · DEN Open · doi:10.1002/deo2.109 · Cited by 21
Luu, H. N., Qi, M., Wang, R., Adams-Haduch, J., Miljkovic, I., Opresko, P. L., Jin, A., Koh, W.-P., & Yuan, J.-M. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000043 · Cited by 20
Sailem, H. Z., Rittscher, J., & Pelkmans, L. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199083 · Cited by 16
Metadata
- Authors
- Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-11-05
- Volume
- 1
- Issue
- 1
- Pages
- 15065-15065
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211001330
- Cited by
- 1,563
- References
- 211
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.